Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy
Increased copy number alterations, indicative of chromosomal instability, is associated with poor cancer outcome. Here, metastatic colorectal cancer patients displaying intermediate-high CIN associate with improved outcome following chemotherapy and bevacizumab treatment, suggesting CIN as a predict...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
05 October 2018
|
| In: |
Nature Communications
Year: 2018, Jahrgang: 9, Pages: 1-16 |
| ISSN: | 2041-1723 |
| DOI: | 10.1038/s41467-018-06567-6 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1038/s41467-018-06567-6 Verlag, Volltext: https://www.nature.com/articles/s41467-018-06567-6 |
| Verfasserangaben: | Dominiek Smeets et al. |
| Zusammenfassung: | Increased copy number alterations, indicative of chromosomal instability, is associated with poor cancer outcome. Here, metastatic colorectal cancer patients displaying intermediate-high CIN associate with improved outcome following chemotherapy and bevacizumab treatment, suggesting CIN as a predictive biomarker. |
|---|---|
| Beschreibung: | Gesehen am 13.12.2019 |
| Beschreibung: | Online Resource |
| ISSN: | 2041-1723 |
| DOI: | 10.1038/s41467-018-06567-6 |